Could a common cosmetic drug shrink painful skin tumors?
NCT ID NCT06300502
Summary
This early-stage study is testing whether giving monthly injections of an FDA-approved drug called Kybella (deoxycholate) can safely reduce the size and improve the appearance of skin tumors in adults with Neurofibromatosis Type 1. Researchers will treat up to 50 tumors in a single body area over six months, comparing them to untreated tumors. The main goals are to see if the treatment is well-tolerated and if it can shrink individual tumors by more than half.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROFIBROMATOSIS 1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wellman Center for Photomedicine
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.